First Time Loading...

Yield10 Bioscience Inc
NASDAQ:YTEN

Watchlist Manager
Yield10 Bioscience Inc Logo
Yield10 Bioscience Inc
NASDAQ:YTEN
Watchlist
Price: 0.239 USD 1.92% Market Closed
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

YTEN Price Targets Summary
Yield10 Bioscience Inc

Wall Street analysts forecast YTEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for YTEN is 0.51 USD with a low forecast of 0.505 USD and a high forecast of 0.525 USD.

YTEN Lowest Forecast
Wall Street Target
0.505 USD
111% Upside
YTEN Average Forecast
Wall Street Target
0.51 USD
113% Upside
YTEN Highest Forecast
Wall Street Target
0.525 USD
120% Upside
Lowest
Price Target
0.505 USD
111% Upside
Average
Price Target
0.51 USD
113% Upside
Highest
Price Target
0.525 USD
120% Upside

YTEN Last Price Targets
Yield10 Bioscience Inc

The latest public price target was made on Mar 26, 2024 by Ben Klieve from Loop Capital Markets , who expects YTEN stock to rise by 109% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ben Klieve
Loop Capital Markets
0.5 USD
Upside 109%
1 month ago
Mar 26, 2024
Lake Street Capital Markets Downgrades Yield10 Bioscience Inc (YTEN) to Hold on funding overhang
StreetInsider
Ben Klieve
Loop Capital Markets
Price Target 0.5 USD
Upside/Downside 109%
View Source
Yield10 Bioscience Inc Competitors:
Price Targets
300653
Yantai Zhenghai Bio-Tech Co Ltd
53% Upside
TNGX
Tango Therapeutics Inc
145% Upside
DVAX
Dynavax Technologies Corp
135% Upside
ARWR
Arrowhead Pharmaceuticals Inc
158% Upside
300653
Yantai Zhenghai Bio-Tech Co Ltd
53% Upside
TNGX
Tango Therapeutics Inc
145% Upside
DVAX
Dynavax Technologies Corp
135% Upside
ARWR
Arrowhead Pharmaceuticals Inc
158% Upside
3164
GenMont Biotech Inc
360% Upside
INCY
Incyte Corp
50% Upside
KDNY
Chinook Therapeutics Inc
1% Downside
87S
Roivant Sciences Ltd
50% Upside

Revenue
Forecast

Revenue Estimate
Yield10 Bioscience Inc

For the last 8 years the compound annual growth rate for Yield10 Bioscience Inc's revenue is -32%. The projected CAGR for the next 3 years is 669%.

-32%
Past Growth
669%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Yield10 Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Yield10 Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-78%
Average Miss
What are analyst estimates?

See Also

Summary
YTEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
YTEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
YTEN stock valuation using valuation multiples.
Wall Street Estimates
YTEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
YTEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is YTEN's stock price target?
Price Target
0.51 USD

According to Wall Street analysts, the average 1-year price target for YTEN is 0.51 USD with a low forecast of 0.505 USD and a high forecast of 0.525 USD.

What is Yield10 Bioscience Inc's Revenue forecast?
Projected CAGR
669%

For the last 8 years the compound annual growth rate for Yield10 Bioscience Inc's revenue is -32%. The projected CAGR for the next 3 years is 669%.

ALPHA SPREAD
Join more than 131,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.